Lumosa Therapeutics Co Ltd (Lumosa Therapeutics), formerly SunTen Phytotech Co., Ltd., is a biotechnology company that offers development of new drugs for the treatment of unmet medical needs. The companys product pipeline includes LT-1001 is under phase 3 clonical trial is used for moderate to severe pain, LT-2001 is under preclinical study used for tumor and cancer and LT-3001 is under preclinical study used for acute ischemic stroke. Its activities include translational research, preclinical, intellectual property regulatory affairs, clinical development, project management, and business development. Lumosa Therapeutics products are used in the areas such as neural, hypertension, diabetic foot ulcer, oncology and inflammatory diseases. The company operates through biotech and pharmaceutical companies for product licensing, development, and commercialization. Lumosa Therapeutics is headquartered in Taipei, Taiwan.
This comprehensive SWOT profile of Lumosa Therapeutics Co Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Lumosa Therapeutics Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the companys operations and business divisions.
Corporate strategy-Analysts summarization of the companys business strategy.
SWOT Analysis-A detailed analysis of the companys strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Lumosa Therapeutics Co Ltd-Key Information
Lumosa Therapeutics Co Ltd-Overview
Lumosa Therapeutics Co Ltd-Key Employees
Lumosa Therapeutics Co Ltd-Key Employee Biographies
Lumosa Therapeutics Co Ltd-Key Operational Heads
Lumosa Therapeutics Co Ltd-Major Products and Services
Lumosa Therapeutics Co Ltd-History
Lumosa Therapeutics Co Ltd-Company Statement
Lumosa Therapeutics Co Ltd-Locations And Subsidiaries
Lumosa Therapeutics Co Ltd-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Lumosa Therapeutics Co Ltd-Business Description
Lumosa Therapeutics Co Ltd-Corporate Strategy
Lumosa Therapeutics Co Ltd-SWOT Analysis
Lumosa Therapeutics Co Ltd-Strengths
Lumosa Therapeutics Co Ltd-Weaknesses
Lumosa Therapeutics Co Ltd-Opportunities
Lumosa Therapeutics Co Ltd-Threats
Lumosa Therapeutics Co Ltd-Key Competitors
Section 3-Company Financial Performance Charts
Lumosa Therapeutics Co Ltd-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Lumosa Therapeutics Co Ltd, Performance Chart
Lumosa Therapeutics Co Ltd, Ratio Charts
List of Tables
Lumosa Therapeutics Co Ltd, Key Information
Lumosa Therapeutics Co Ltd, Key Ratios
Lumosa Therapeutics Co Ltd, Share Data
Lumosa Therapeutics Co Ltd, Major Products and Services
Lumosa Therapeutics Co Ltd, History
Lumosa Therapeutics Co Ltd, Key Employees
Lumosa Therapeutics Co Ltd, Key Employee Biographies
Lumosa Therapeutics Co Ltd, Key Operational Heads
Lumosa Therapeutics Co Ltd, Other Locations
Lumosa Therapeutics Co Ltd, Subsidiaries
Lumosa Therapeutics Co Ltd, Key Manufacturing facilities
Lumosa Therapeutics Co Ltd, Key Competitors
Lumosa Therapeutics Co Ltd, SWOT Analysis
Lumosa Therapeutics Co Ltd, Ratios based on current share price
Lumosa Therapeutics Co Ltd, Annual Ratios
Lumosa Therapeutics Co Ltd, Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
Lumosa Therapeutics Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"